Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
10,763.65156.3
Stock Analysis, IPO, Mutual Funds, Bonds & More
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial

The DCGI has approved the company's remdesivir 100 mg per vial for restricted emergency use in India as part of the regulator's accelerated approval process to address urgent, unmet needs amid the evolving COVID-19 pandemic, Mylan said in a statement.

Zydus Cadila gets approval from Mexican authority to test COVID-19 drug

Last week, Zydus had received approval from Indian authorities to start human trials for its COVID-19 vaccine contender - the second Indian pharmaceutical firm to get such nod amid a surge in novel coronavirus infections worldwide.

India could have its own Corona vaccine by Independence day

The Indian council of Medical Research (ICMR) plans to launch indigenous vaccines for COVID-19 by August 15 after the completion of the clinical trials.

NIH and DBT to review vaccine candidates for Covid-19 this week

The meeting will see research groups and vaccine developers funded through India-US tieups present their progress on Covid-19 vaccines and discuss ways to take the development forward.

Two weeks to start the trial, six months at least to finish: Experts

The ICMR had created a stir by stating that the plan was to launch the Covid vaccine on August 15.

Indian drug firms recall products in US market

While Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US market.

Scientists discover small proteins which may reduce inflammation caused by COVID-19

The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring small proteins, or peptides.

WHO ending hydroxycholorquine trial for COVID

WHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir "produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care."

Experts in two minds over ICMR's August 15 date for Covid-19 vaccine launch

Investigators listed for Bharat Biotech trials said it was impossible to have a vaccine by August.

COVID-19 vaccine: India aims to release indigenous 'Covaxin' by August 15, 2020; ICMR ramps up efforts

Aiming to launch an indigenous COVID-19 vaccine by August 15, the Indian Council of Medical Research has written to select medical institutions and hospitals to fast-track clinical trial approvals for the vaccine candidate Covaxin being developed in collaboration with Bharat Biotech. Twelve clinical trial sites have been identified at present and the apex health research body has asked the medical institutions and principal investigators to ensure that the subject enrollment is initiated no later than July 7.

Bharat Biotech: Hyderabad company among frontrunners for a Covid vaccine

Bharat Biotech has got nod from the DCGI to begin human trials of the first indigenous Covid-19 vaccine.

ICMR-Bharat Biotech COVID-19 vaccine trial results to be released by Aug 15

ICMR-Bharat Biotech COVID-19 vaccine trial results to be released by Aug 15

A total of 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered the topmost priority projects which are being monitored by the government.

COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

COVID-19 vaccine by Ahmedabad-based Zydus Cadila gets DCGI nod for human clinical trials

The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the vaccine candidate was found to be successful with respect to safety and immunogenicity, sources said.

Drug makers get nod to raise one-time price increase on heparin injections

Drug makers get nod to raise one-time price increase on heparin injections

The NPPA has allowed for upward revision of heparin injection 1000IU/ ml and heparin injection 5000IU/ ml under para 19 of DPCO 2013 by 50%. The ceiling price of the drug is now fixed at Rs 24 and Rs 60.

Gilead won't launch its Covid drug in July

Gilead won't launch its Covid drug in July

Gilead has issued licences to nine generic drug companies to make and sell remdesivir. Six of the companies are Indian - Hetero, Cipla, Dr Reddy's Laboratories, Zydus Cadila, Jubilant Life Sciences and Syngene/Biocon. Besides Hetero, Cipla is the only other Indian company to receive marketing approval from India's drug regulator.

Cadila Healthcare Ltd may soon start human trials of vaccine

Cadila Healthcare Ltd may soon start human trials of vaccine

At a recent meeting at the Central Drugs Standard Control Organisation (CDSCO)-the regulatory authority of India, subject experts recommended the Drug Controller General of India (DCGI) to grant permission to the company for starting human trials.

Load More...

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

BACK TO TOP